This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignees: The Salk Institute, Scripps Research Institute. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- La Jolla, CA (US) (2023)
- San Diego, CA (US) (2023)
Company Filing History:
Years Active: 2023-2026
Title: Innovations by Lei Zhang in Synthetic Adenoviruses
Introduction
Lei Zhang is an accomplished inventor based in La Jolla, California. He has made significant contributions to the field of synthetic adenoviruses, focusing on their applications in tumor targeting and tissue regeneration. With a total of two patents to his name, Zhang's work is paving the way for advancements in medical therapies.
Latest Patents
Zhang's latest patents include innovative synthetic adenoviruses designed for specific medical applications. The first patent describes tumor-targeting synthetic adenoviruses that possess liver detargeting mutations and express an adenovirus type 34 (Ad34) fiber protein. These synthetic adenoviruses are engineered to traffic directly to tumor sites, allowing for the delivery of diagnostic or therapeutic transgenes. The second patent focuses on synthetic adenoviruses with tropism to damaged tissue, which are capable of promoting wound repair and tissue regeneration. These vectors can specifically infect cells at wound sites and express transgenes that aid in healing, making them valuable tools in regenerative medicine.
Career Highlights
Zhang is affiliated with the Salk Institute for Biological Studies, where he conducts his research. His work has garnered attention for its potential to revolutionize treatments for cancer and tissue injuries. The innovative nature of his patents reflects his commitment to advancing medical science through technology.
Collaborations
Zhang collaborates with notable colleagues, including Clodagh O'Shea and Colin Powers. Their combined expertise enhances the research and development of synthetic adenoviruses, contributing to the success of their projects.
Conclusion
Lei Zhang's contributions to the field of synthetic adenoviruses represent a significant advancement in medical technology. His innovative patents have the potential to improve therapeutic strategies for cancer treatment and tissue regeneration. The impact of his work is likely to be felt in the medical community for years to come.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile